The goal of the Digestive Disease Epidemiology Training Program at the University of North Carolina is to train independent researchers who will improve our understanding of the magnitude, etiology and impact of digestive diseases, and who will assume leadership roles in GI epidemiology and outcomes research. To accomplish that mission, the program includes a comprehensive curriculum with the following features: 1) formal advanced training in epidemiologic methods and biostatistics;2) a 2 - 3 year period of training culminating in an MPH, MSCR or PhD in epidemiology;3) emphasis on design, execution, analysis and publication of a research project;4) mentors to guide the developing investigator;5) an integrative core curriculum designed to develop additional skills necessary for an academic career;6) concurrent training of MD and PhD candidates in a program that ranges from molecular epidemiology to population-based health outcomes research;7) a training advisory committee with diverse membership to encourage breadth of vision by the trainees. The training program is designed to support one-pre-doctoral and three post-doctoral candidates each year. The program takes advantage of unique and considerable institutional strengths in public health and gastroenterology. A stable, diverse, and multidisciplinary faculty provides trainees expert guidance in epidemiology, biostatistics, and health outcomes research. The training faculty of 17 includes 16 members of the adult and pediatric GI Divisions of whom 11 have advanced training in epidemiology or biostatistics. The active research programs of the training faculty are well funded from federal sources. Prior trainees in this program have remarkable records of publication and success in obtaining faculty positions on completion of the fellowship.

Public Health Relevance

Digestive diseases have a major impact on health in the United States. The proposed Digestive Disease Epidemiology Training Program will develop independent researchers who will improve our understanding of the magnitude, etiology and impact of digestive diseases, and who will assume leadership roles in GI epidemiology and outcomes research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
3T32DK007634-25S1
Application #
8868559
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Densmore, Christine L
Project Start
1990-07-10
Project End
2019-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
25
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Cotton, Cary C; Haidry, Rehan; Thrift, Aaron P et al. (2018) Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology 155:316-326.e6
Eluri, Swathi; Cross, Raymond K; Martin, Christopher et al. (2018) Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life. Dig Dis Sci 63:1572-1582
Lieber, Sarah R; Schiano, Thomas D; Rhodes, Rosamond (2018) Should living donor liver transplantation be an option when deceased donation is not? J Hepatol 68:1076-1082
Reed, Craig C; Koutlas, Nathaniel T; Robey, Benjamin S et al. (2018) Prolonged Time to Diagnosis of Eosinophilic Esophagitis Despite Increasing Knowledge of the Disease. Clin Gastroenterol Hepatol 16:1667-1669
James, Theodore W; Baron, Todd H (2018) Antegrade ERCP through a spontaneous gastrogastric fistula in a patient with Roux-en-Y postsurgical anatomy. Gastrointest Endosc 87:1154-1155
Reed, Craig C; Shaheen, Nicholas J (2018) Natural History of the Post-ablation Esophagus. Dig Dis Sci 63:2136-2145
Reed, Craig C; Fan, Claire; Koutlas, Nathaniel et al. (2018) Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis. HSOA J Gastroenterol Hepatol Res 7:2509-2515
Kim, Hannah P; Reed, Craig C; Herfarth, Hans H et al. (2018) Vedolizumab Treatment May Reduce Steroid Burden and Improve Histology in Patients With Eosinophilic Gastroenteritis. Clin Gastroenterol Hepatol 16:1992-1994
Eluri, Swathi; Shaheen, Nicholas J (2018) IMportance of an Irregular Z Line: Is Barrett's in the Eye of the Beholder? Dig Dis Sci 63:1378-1380
Koutlas, N T; Eluri, S; Rusin, S et al. (2018) Impact of smoking, alcohol consumption, and NSAID use on risk for and phenotypes of eosinophilic esophagitis. Dis Esophagus 31:1-7

Showing the most recent 10 out of 238 publications